Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. - Wikidata - wikimedia - TriplyDB

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

http://www.wikidata.org/entity/Q37098433

about

Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration Angiogenic factors in preeclampsia: potential for diagnosis and treatment Vascular endothelial growth factor-B in physiology and disease Angiogenic factors in diagnosis, management, and research in preeclampsia.Prevalence of pregnancy hypertensive disorders in Mongolia Intraplacental gene therapy with Ad-IGF-1 corrects naturally occurring rabbit model of intrauterine growth restriction.Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia Maternal Smoking during Pregnancy and Daughters' Preeclampsia Risk Cluster analysis to estimate the risk of preeclampsia in the high-risk Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study.Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines Urinary Concentrations of Bisphenol A and Phthalate Metabolites Measured during Pregnancy and Risk of Preeclampsia.Placental disease and the maternal syndrome of preeclampsia: missing links?Pre-eclampsia part 2: prediction, prevention and management.Understanding Pre-Eclampsia Using Alzheimer's Etiology: An Intriguing Viewpoint.Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction.Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question).A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy.Hypertension in Pregnancy: Defining Blood Pressure Goals and the Value of Biomarkers for Preeclampsia.Validation of hospital discharge diagnoses for hypertensive disorders of pregnancy.Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia.Angiogenic factors: Potential to change clinical practice in preeclampsia?Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy: A Systematic Review.Metabolic and Hypertensive Complications of Pregnancy in Women with Nephrolithiasis.The imbalance of circulating angiogenic/antiangiogenic factors is mild or absent in obese women destined to develop preeclampsia.Preeclampsia and superimposed preeclampsia: The same disease? The role of angiogenic biomarkers.Response to Carbillon L et al. letter titled; "The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia".Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.Molecular Mechanisms of Preeclampsia.Analysis of changes in maternal circulating angiogenic factors throughout pregnancy for the prediction of preeclampsia.

P2860

Q26796661-307201D1-ACF1-4FE9-ABB6-7E1D77CCE012 Q26825774-7AEEB614-0812-477B-A77F-229B05C56DD1 Q27003400-5AFCEBC3-808E-4BFA-9299-B3421A25736A Q27692060-A6170FEA-562A-4F62-A828-CDE001E413B7 Q33437521-2DC31B0B-A808-4A41-8647-BDA8883A113A Q35199313-35BA0E71-FC91-42BD-BED5-C50F3EED97FF Q35538277-D0BFCA95-80C5-4F0D-9B64-47E0C344409C Q35858908-5A065DB5-4A2E-48DD-8272-3F982CC9E294 Q36325415-36369CD0-6632-4027-A4BB-E8DA453E2205 Q36965155-EC7AD599-C0BD-456F-BB0A-ED333ED0AD51 Q37306116-8106061F-5C42-4863-961B-F8D53D1F8854 Q37337545-AD2A0E6B-5CD2-49F1-B99C-97CCD46A65E7 Q38227251-5C7B67BD-2DE0-4946-BB9D-982163714BD4 Q38638997-25B97954-C3F5-44F2-89AA-44FE64C57199 Q38796954-024A287C-4977-4CA1-B7B5-DCA5E24C7578 Q38806961-5C7DE69E-D91E-4785-B0BB-A54554653B44 Q38824646-B08D5FDA-85CE-4520-B3F8-CEB8CEC15E6A Q39006055-FD9557B4-2702-46D7-A43B-D5F22AFFFD08 Q39452231-6A349CB5-3D15-4739-91DB-6E2E757B69AA Q39783174-6611090B-4395-48C5-B5BA-88B6A19E2F71 Q44121356-0668B97A-0487-4D83-A38B-48AEA4C47823 Q46301113-95C1F1D2-8843-4076-A9BB-88B6C80C148C Q47154280-F81DD408-67A8-44D8-91E7-9BE516B2A789 Q52689248-B12B4ECE-8715-4118-8B17-E83F8980ADBC Q53710143-3FCA8D57-00C0-4889-BE64-E5474B881562 Q54211349-3F651261-FDA4-4D9E-80A9-002C0539B595 Q54334562-2FB1F007-382B-4506-A9A1-502C32A893FA Q54386144-EAF9C0CE-AA9A-486A-8F7D-0F51BA34BB4F Q54901493-51C30B3B-B328-4AA4-A2F8-A5ED9A0D1EED Q55036332-3A7DDD6C-6A8D-4B71-B442-AF56CB94E05D

P2860

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

http://www.wikidata.org/entity/Q37098433

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

@en

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

@nl

type

label

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

@en

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

@nl

prefLabel

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

@en

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

@nl

P1433

Q37098433-7D2AF74F-0760-43D1-A22A-B3F5B0F1C62C

P1476

Q37098433-AE0C8B64-7318-41C1-A287-21FFB9D75EDF

P2093

Q37098433-04B19453-CB56-43D0-8ADB-1C3F85F1E600

Q37098433-145E1A6A-454C-408C-9628-A4544BF10C4B

Q37098433-148F546F-1DFC-4AAF-B1B4-FB84D25172D4

Q37098433-37E3078E-76A7-40E1-B267-FCBBB8F2CC4F

Q37098433-46C4F3D5-C264-442D-B5A2-A6B48F92BDE7

Q37098433-58CB9635-DB1C-401D-B4B2-26B2824BE8D8

Q37098433-5C13D756-CA7B-4CD1-9D8B-124D0E3BA093

Q37098433-71AD083B-666C-4B84-BD11-27850C8FC5FC

Q37098433-E0D948FE-CC00-46B9-A403-00B61B895AFC

Q37098433-E2CCC780-C169-499B-80AD-BDE3A9FBFA08

P2860

Q37098433-1D99B527-C103-41A1-B811-4F831E6BFCA0

Q37098433-34F41185-BE8F-45FA-8742-22467B720095

Q37098433-355BF649-DADB-4DDD-939D-DDE86B0D366B

Q37098433-381B5E4C-FA97-4BE7-862B-770C0DBCA81C

Q37098433-3C5E8A36-6A47-44F9-A042-D98A6FBF0BD1

Q37098433-3F227C23-EE3E-4137-8E5D-49B031297227

Q37098433-47FF98E5-A371-463A-A817-298B112B7B4F

Q37098433-488E5243-E792-4284-B424-4D8F1ED275FF

Q37098433-4EBF720C-EEB1-453A-BFBF-7F5F8E51036B

Q37098433-5990D04E-9D05-4007-AB15-1A66A4A482DC

P304

Q37098433-C75BDC11-3786-429C-A5D0-BB89072AD607

P31

Q37098433-94EA54C0-7AAC-41C5-A7BF-6073CD9B08B3

P356

Q37098433-2379DA31-299F-4003-9A9D-F8E19E140F6E

P433

Q37098433-B9940231-56C7-4817-B912-5502C085A4BE

P478

Q37098433-75447BD6-649F-4299-BE3F-183C52762726

P50

Q37098433-1BF75D82-BC2B-481B-A61D-A6F00983EE3D

Q37098433-DD4DDC12-019D-4652-9F4F-AAD3675EB020

P577

Q37098433-7997A2D6-F5C9-4B59-A1C6-9E55AE706D51

P5875

Q37098433-3A8D77EA-441B-48EB-BBC9-3FF8DC65F2EE

P698

Q37098433-0B5684D8-A352-41E2-98B1-B36A19603407

P921

Q37098433-17889B46-D676-48D1-AAEC-A39A405F0325

P932

Q37098433-69A202BE-336A-4207-ACD9-45D1E52EA180

P356

10641955.2013.784788

P1433

Hypertension in Pregnancy

P1476

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

@en

P2093

Ana Sofia Cerdeira

http://www.w3.org/2001/XMLSchema#string

Camille Powe

http://www.w3.org/2001/XMLSchema#string

Frank H Perschel

http://www.w3.org/2001/XMLSchema#string

Julia Wenger

http://www.w3.org/2001/XMLSchema#string

Kee-Hak Lim

http://www.w3.org/2001/XMLSchema#string

Ravi Thadhani

http://www.w3.org/2001/XMLSchema#string

Saira Salahuddin

http://www.w3.org/2001/XMLSchema#string

Sarosh Rana

http://www.w3.org/2001/XMLSchema#string

William T Schnettler

http://www.w3.org/2001/XMLSchema#string

Zoltan Arany

http://www.w3.org/2001/XMLSchema#string

P2860

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes.

Vitamins C and E to prevent complications of pregnancy-associated hypertension

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

Early onset pre-eclampsia: recognition of underlying renal disease.

Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia

Lupus nephritis and renal disease in pregnancy.

Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model

Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

P304

189-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10641955.2013.784788

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Stefan Verlohren

S Ananth Karumanchi

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237001352

http://www.w3.org/2001/XMLSchema#string

P698

23725084

http://www.w3.org/2001/XMLSchema#string

P921

P932

3744824

http://www.w3.org/2001/XMLSchema#string